The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
Open accessAbstract
Colorectal cancer (CRC) is the third most common cancer and has a high metastasis and reoccurrence rate. Long noncoding RNAs (lncRNAs) play an important role in CRC growth and metastasis. Recent studies revealed that lncRNAs participate in CRC progression by coordinating with microRNAs (miRNAs) and protein-coding mRNAs. LncRNAs function as competitive endogenous RNAs (ceRNAs) by competitively occupying the shared binding sequences of miRNAs, thus sequestering the miRNAs and changing the expression of their downstream target genes. Such ceRNA networks formed by lncRNA/miRNA/mRNA interactions have been found in a broad spectrum of biological processes in CRC, including liver metastasis, epithelial to mesenchymal transition (EMT), inflammation formation, and chemo-/radioresistance. In this review, we summarize typical paradigms of lncRNA-associated ceRNA networks, which are involved in the underlying molecular mechanisms of CRC initiation and progression. We comprehensively discuss the competitive crosstalk among RNA transcripts and the novel targets for CRC prognosis and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10 retracted
RETRACTED: MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin
Zhang, J., Liu, D., Feng, Z., Mao, J., Zhang, C., Lü, Y., Li, J., Zhang, Q., Li, Q., & Li, L. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.018 · Cited by 98
RetractedSun, J., Hu, J., Wang, G., Yang, Z., Zhao, C., Zhang, X., & Wang, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0771-x · Cited by 91
RetractedFu, F., Wang, T., Wu, Z., Feng, Y., Wang, W., Zhou, S., Ma, X., & Wang, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0683-x · Cited by 87
RetractedZhu, J. Y., Zhang, R., Yang, D., Li, J., Yan, X., Jin, K., Li, W., Liu, X., Zhao, J., Shang, W., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495168 · Cited by 87
RetractedLin, C., Zhang, Y., Chen, Y., Bai, Y., & Zhang, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1352-4 · Cited by 70
RetractedYang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3941 · Cited by 70
RetractedShi, L., Hong, X., Ba, L., He, X., Xiong, Y., Ding, Q., Yang, S., & Peng, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1332-8 · Cited by 69
RetractedYang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5206 · Cited by 60
RetractedmiR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
Wen, C., Liu, X., Ma, H., Zhang, W., & Li, H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2929 · Cited by 38
RetractedWang, K., Zhang, M., Wang, C., & Ning, X. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15234931503876 · Cited by 14
Retracted
Cited by
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Mechanisms of Taxane Resistance
Maloney, S., Spring, C., Morejon-Lasso, L., & Prosperi, J. (2020) · Cancers · doi:10.3390/cancers12113323 · Cited by 198
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Novel strategies to reverse chemoresistance in colorectal cancer
Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., & Li, L. (2023) · Cancer Medicine · doi:10.1002/cam4.5594 · Cited by 108
Wu, H., Ding, X., Hu, X., Zhao, Q., Chen, Q., Sun, T., Li, Y., Guo, H., Li, M., Gao, Z., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02189-x · Cited by 26
Self-citation
Metadata
- Authors
- Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-11-16
- Volume
- 20
- Issue
- 22
- Pages
- 5758
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2986494140
- Cited by
- 605
- References
- 161
- FWCI
- 24.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. https://app.cochat.ai/papers/10.3390/ijms20225758
- The paper
- Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019). Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms20225758
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.